Giraudo Bryan's most recent trade in Gossamer Bio Inc was a trade of 638,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 4, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Gossamer Bio Inc | Bryan Giraudo | COO/CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 638,000 | 638,000 | - | - | Stock Option (Right to Buy) | |
| Protagonist Therapeutics Inc | Bryan Giraudo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 6,584 | 6,584 | - | - | Stock Option (right to buy) | |
| Protagonist Therapeutics Inc | Bryan Giraudo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 5,130 | 15,130 (0%) | 0% | 0 | Common Stock | |
| Gossamer Bio Inc | Bryan Giraudo | COO/CFO | Purchase of securities on an exchange or from another person at price $ 0.59 per share. | 18 Jun 2024 | 100,000 | 480,010 (0%) | 0% | 0.6 | 59,110 | Common Stock |
| Gossamer Bio Inc | Bryan Giraudo | COO/CFO | Sale of securities on an exchange or to another person at price $ 1.16 per share. | 27 Mar 2024 | 6,430 | 92,737 (0%) | 0% | 1.2 | 7,431 | Common Stock |
| Gossamer Bio Inc | Giraudo Bryan | COO/CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 543,750 | 543,750 | - | - | Stock Option (Right to Buy) | |
| Protagonist Therapeutics Inc | Giraudo Bryan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 25,700 | 25,700 | - | - | Stock Option (right to buy) | |
| Gossamer Bio Inc | Bryan Giraudo | COO/CFO | Grant, award, or other acquisition of securities at price $ 1.82 per share. | 24 Jul 2023 | 54,020 | 180,010 (0%) | 0% | 1.8 | 98,316 | Common Stock |
| Gossamer Bio Inc | Bryan Giraudo | COO/CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jul 2023 | 13,505 | 13,505 | - | - | Common Stock | |
| Gossamer Bio Inc | Bryan Giraudo | COO/CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 May 2023 | 265,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Bryan Giraudo | COO/CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2023 | 176,667 | 176,667 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Bryan Giraudo | COO/CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 May 2023 | 150,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Bryan Giraudo | COO/CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 May 2023 | 145,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Bryan Giraudo | COO/CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2023 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Bryan Giraudo | COO/CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2023 | 96,667 | 96,667 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Bryan Giraudo | COO/CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 May 2023 | 90,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Bryan Giraudo | COO/CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 May 2023 | 71,500 | 0 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Bryan Giraudo | COO/CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2023 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Bryan Giraudo | COO/CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2023 | 47,667 | 47,667 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Bryan Giraudo | COO/CFO | Purchase of securities on an exchange or from another person at price $ 1.02 per share. | 04 Apr 2023 | 55,000 | 125,990 (0%) | 0% | 1.0 | 56,095 | Common Stock |
| Gossamer Bio Inc | Bryan Giraudo | COO/CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Mar 2023 | 211,500 | 211,500 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Bryan Giraudo | COO/CFO | Purchase of securities on an exchange or from another person at price $ 0.97 per share. | 20 Mar 2023 | 50,000 | 70,990 (0%) | 0% | 1.0 | 48,435 | Common Stock |
| Protagonist Therapeutics Inc | Bryan Giraudo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2023 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Gossamer Bio Inc | Bryan Giraudo | COO/CFO | Purchase of securities on an exchange or from another person at price $ 7.21 per share. | 15 Jul 2022 | 13,869 | 20,990 (0%) | 0% | 7.2 | 99,995 | Common Stock |
| Protagonist Therapeutics Inc | Bryan Giraudo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2022 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Gossamer Bio Inc | Bryan Giraudo | COO/CFO | Sale of securities on an exchange or to another person at price $ 8.92 per share. | 23 Mar 2022 | 10,722 | 99,167 (0%) | 0% | 8.9 | 95,587 | Common Stock |
| Gossamer Bio Inc | Bryan Giraudo | COO/CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2022 | 265,000 | 265,000 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Bryan Giraudo | COO/CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Sep 2021 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Protagonist Therapeutics Inc | Bryan Giraudo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2021 | 18,000 | 18,000 | - | - | Stock Option (right to buy) | |
| Gossamer Bio Inc | Bryan Giraudo | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 9.48 per share. | 23 Mar 2021 | 5,490 | 109,889 (0%) | 0% | 9.5 | 52,046 | Common Stock |
| Gossamer Bio Inc | Bryan Giraudo | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 90,000 | 90,000 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Bryan Giraudo | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 45,000 | 115,379 (0%) | 0% | 0 | Common Stock | |
| Gossamer Bio Inc | Bryan Giraudo | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 10.01 per share. | 14 Oct 2020 | 3,000 | 7,121 (0%) | 0% | 10.0 | 30,036 | Common Stock |